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Despite the importance of cardiomyocyte proliferation in cardiac development and regen-
eration, the mechanisms that promote cardiomyocyte cell cycle remain incompletely
understood. RE1 silencing transcription factor (REST) is a transcriptional repressor of neu-
ronal genes. Here we show that REST also regulates the cardiomyocyte cell cycle. REST binds
and represses the cell cycle inhibitor gene p21 and is required for mouse cardiac development
and regeneration. Rest deletion de-represses p21 and inhibits the cardiomyocyte cell cycle and
proliferation in embryonic or regenerating hearts. By contrast, REST overexpression in cul-
tured cardiomyocytes represses p21 and increases proliferation. We further show that p21
knockout rescues cardiomyocyte cell cycle and proliferation defects resulting from Rest
deletion. Our study reveals a REST-p21 regulatory axis as a mechanism for cell cycle pro-
gression in cardiomyocytes, which might be exploited therapeutically to enhance cardiac
regeneration.
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Cardiomyocyte proliferation is required for generatingmyocardial mass and building a functional four-chamberheart during embryonic development1–3. After birth, car-
diomyocytes continue to proliferate in a short neonatal period,
which is crucial for the ﬁnal cardiac growth surge as well as for
regeneration of injured mouse neonatal hearts4–6. The vast
majority of cardiomyocytes then exits the cell cycle and stops
proliferating after preadolescence7–10. The inability of
cardiomyocytes to proliferate prevents the replenishment of lost
or dysfunctional cells in a diseased heart11. Because heart diseases
are the number one cause of death worldwide11, it is important to
identify the regulatory factors of the cardiomyocyte cell cycle,
which may be used as therapeutic targets for these devastating
conditions.
Several transcription factors, such as GATA412, TBX2013,
BRG114, YAP15,16, ERBB217, PITX218, and MEIS119 have been
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Fig. 1 Rest is required for myocardial development and cardiomyocyte proliferation. a, b Immunostaining and western blot analyses showing the efﬁcient
deletion of Rest in cardiomyocytes in TnTCre;RestGT/GT (RestmKO) hearts. Controls were RestGT/GT mice. c A summarizing graph of the distribution and
number of embryos at different stages indicates death of Restmko embryos between E12.5 and E16.5. d, e H&E-stained sections of E10.5 and E12.5 hearts
indicate thin ventricular wall resulting from Rest deletion. f Quantitative immunostaining of cell cycle markers showing reduced proliferation of RestmKO
cardiomyocytes. n= 4/group, mean± s.d., *p< 0.05 by unpaired two-tailed Student’s t test. Scale bars= 40 µm
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shown to be essential for cardiomyocyte proliferation during
development and for regeneration following neonatal heart
injury. Transcriptional repressor element-1 silencing transcrip-
tion factor (REST), also known as neuron-restrictive silencer
factor (NRSF), is widely expressed in the embryonic tissues20,21. It
binds a cis-element of 21 nucleotide base pairs, named RE1
motif22, to silence the expression of neuronal genes in the non-
neuronal cells required for neurogenesis23,24. We have recently
reported REST acting as a transcription repressor in mouse
embryonic hearts20. In this study, we reveal that suppression of
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Fig. 2 Rest is required for neonatal cardiomyocyte proliferation and cardiac function. a A graph of experimental design for generating myocardial Rest
knockout (RestimKO) at different postnatal (P) stages using the inducible TnTMerCreMer deleter mice. b Western blots showing effective deletion of Rest. c
Survival curve of control and RestimKO mice, p< 0.001, log-rank (Mantel–Cox) testing between mice with Rest deletion at different stages and control (Tam-
treated Rest+/+;TnTMerCreMer/+ mice). d Representative H&E staining and heart/body weight ratio revealing underdeveloped RestimKO hearts at P3 after Rest
deletion at P1. n= 5/group. Scale bar= 100 µm. e–g Echocardiography showing structure defects and decreased left ventricle function of P3 RestimKO. n= 6
for RestimKO; n= 8 for Control. h–j FACS shows reduced percentage of cardiomyocytes isolated from P3 RestimKO hearts (h) and arrested cell cycle of the
RestimKO cardiomyocytes at G0/G1 phase (i, j). k Immunostaining for cell cycle markers indicating reduced proliferation of Rest null cardiomyocytes. n= 4/
group for FACS and immunostaining. Scale bar= 40 µm. Mean± s.d., *p< 0.05, unpaired two-tailed Student’s t test
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the cell cycle inhibitor gene p21 by REST is critically required
during cardiac development and regeneration to maintain car-
diomyocyte proliferation. We show that REST binds and
represses the cell cycle inhibitor gene p21, which is required for
mouse cardiac development and regeneration. Rest deletion de-
represses p21 and inhibits the cardiomyocyte cell cycle and pro-
liferation in embryonic or regenerating mouse hearts. We also
show that p21 knockout rescues the cardiomyocyte cell cycle and
proliferation defects resulting from Rest deletion. By elucidating
the REST-p21 genetic mechanism underlying the cell cycle reg-
ulation of proliferating cardiomyocytes during cardiac develop-
ment and regeneration, our study provides an opportunity for
developing cell-based therapeutics for heart disease.
Results
Rest is required for embryonic cardiomyocyte proliferation.
Our recent studies showed that REST represses transcription in
mouse embryonic hearts20. Based upon this, we did a time course
of REST expression levels at various developmental stages. By
western blot, we found that REST was downregulated in the
ventricles of neonatal hearts (Supplementary Fig. 1a, b). Further,
immunostaining showed that REST was expressed in the majority
of cardiomyocytes between embryonic day (E) 11.5 and postnatal
day (P) 3, whereas the number of REST-expressing cardiomyo-
cytes was drastically reduced from P3 to P28 (Supplementary
Fig. 1c, d). The downregulation of REST protein level was not
accompanied by a change in mRNA level (Supplementary
Fig. 1e), and was possibly due to the REST protein
degradation21,25.
Given that downregulation of REST coincided with the cell
cycle exit of cardiomyocytes5, we examined the relationship of
REST expression with cardiomyocyte proliferation by immunos-
taining. The results revealed that the majority of EdU+
proliferating cells expressed REST (Supplementary Fig. 2a–c).
We next inactivated Rest in the myocardium (RestmKO) using
TnTCre and RestGT/GT mice23 to determine its role in cardio-
myocytes and conﬁrmed that Rest was effectively deleted in the
myocardium by immunostaining and western blot (Fig. 1a, b).
RestmKO embryos were runted and >80% of them were dead by
E16.5 (Fig. 1c). RestmKO hearts at E10.5–12.5 had thin ventricular
walls and defective trabeculae (Fig. 1d, e). Notably, there was
signiﬁcantly reduced percentage of RestmKO cardiomyocytes that
were expressing the cell cycle markers (Ki67 for cell cycle activity,
EdU for DNA synthesis, pH3 for mitosis, and Aurora B for
cytokinesis) (Fig. 1f). Such proliferation defect was not associated
with changes in myocardial differentiation and apoptosis
(Supplementary Fig. 3a–g). These observations demonstrate that
Rest is essential for embryonic cardiomyocyte proliferation and
chamber development.
Rest is required for neonatal cardiomyocyte proliferation. To
determine whether Rest is also requirement for neonatal cardio-
myocyte proliferation, we deleted Rest at P1, P3, or P7 using an
inducible TnTMerCreMer driver (RestimKO, thereafter) (Fig. 2a, b).
Rest inactivation at P1, but not at P3 or P7, resulted in the death
of ~80% of neonates within 1 week after tamoxifen injection
(Fig. 2c). Based upon this, we focused on inactivating Rest at P1
and investigating the resultant changes in cardiac morphology
and function at P3. H&E staining showed that the RestimKO hearts
were underdeveloped with a reduced ratio of the heart/body
weight (Fig. 2d). Echocardiography revealed a noticeable reduc-
tion in the left ventricular mass, left ventricular wall thickness,
2.0
a b
e f
c
50
2.5
5%
 in
pu
t
lgG lgGlgG lgG
RE
ST
RE
ST
H3
K9
/14
ac
H3
K4
me
3
H3
K9
me
3
H3
K2
7m
e3
RE
ST
RE
ST
5%
 in
pu
t
5%
 in
pu
t
0.6
0.5
0.4
0.3
0.2
0.1
0.0
E12.5 Control
NS
NS
NS
*
*
*
*
P1
P21
1.5
1.0
0.5
0.0
E12.5E12.5
p2
1/
Tn
T 
(%
)
En
ric
hm
en
t o
f R
E-
1 
m
ot
if
R
el
at
iv
e 
ch
an
ge
 to
 5
%
 in
pu
t
P3
Mm9
0 3 kb 6 kb
690 bp
9 kb
Hg18
RE-1 motif
Inter gene
p21-RE1
p2
1/
Tn
T/
DA
PI
Repeat
Coding
UTR
WT
Mut1
Mut2
Del
Intron
P3
*
*
*
d
pGL3-
enhancer
0 0.5
Luciferase activity
1.0 1.5
p2
1-
R
E-
1 
m
ot
if
WT
Mut1
Mut2
Del
*
*
*
*
*
*
40
30
20
10
0
Co
ntr
ol
Co
ntr
ol
Control
Rest imko (iP1)
Rest imKO (iP1)
Re
st
m
Ko
Re
st
im
Ko
Restmko
Control
p21
Fig. 3 REST binds p21 to repress its expression. a, b Immunostaining (n= 4/group) showing upregulated p21 protein level in the Rest deleted E12.5 and P3
hearts. Scale bar= 40 µm. c Top, Sequence alignment of p21 between mouse and human indicating a conserved RE-1 motif (red vertical line) located at the
3′ UTR. Bottom, The p21-RE1 motif and its mutated (Mut) or deleted (Del) counterpart. d Luciferase reporter assays with a 690-bp mouse DNA fragment
containing the wild type (WT), mutated, or deleted RE1 motif reveals that the intact p21-RE1 motif is required for repressing the reporter gene transcription
in primary cultured P1 mouse cardiomyocytes. e qChIP using REST antibodies indicates enrichment of p21-RE1 motif containing DNA fragments in the
ventricles of E12.5 and P1, but not P21. f qChIP with P2 ventricles using the REST and histone mark antibodies showing the REST-dependent histone
modiﬁcation of the p21-RE1 motif. n= 3/group for d–f, mean± s.d., *p< 0.05 by one-way ANOVA followed by Tukey’s test in d; unpaired Student’s t test in
b, e, f. NS no signiﬁcance
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and contractility (Fig. 2e–g). Flow cytometry assays further
revealed a reduced percentage of cardiomyocytes in RestimKO
hearts (Fig. 2h). The null cardiomyocytes were accumulated at the
G0/G1 phase of cell cycle, while their presence at the S and G2/M
phases was reduced (Fig. 2i, j). Immunostaining for Ki67 and
EdU conﬁrmed the cell cycle defect (Fig. 2k). In contrast, Rest
deletion at P3 or P7, when cardiomyocytes were exiting the cell
cycle, had no effect on cardiac morphology and function (Sup-
plementary Fig. 4a–d). Therefore, Rest is also required for
neonatal cardiomyocyte proliferation through maintaining cell
cycle progression, and neonatal cardiac growth and function.
REST binds and represses p21 to regulate cardiomyocyte pro-
liferation. To identify the downstream factor(s) of REST involved
in the cell cycle regulation, we re-analyzed our previously pub-
lished RNA-seq data from E12.5 control versus RestmKO hearts20
and found that p21 (Cdkn1a) was the only cell cycle inhibitor
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gene signiﬁcantly upregulated in Rest null hearts, whereas the
expression of several cell cycle activators was downregulated
(Supplementary Fig. 5a). These ﬁndings were then conﬁrmed by
qRT-PCR (Supplementary Fig. 5b, c). Notably, p21 was also the
only cell cycle inhibitor gene which expression was signiﬁcantly
upregulated in P2 ventricles with myocardial Rest inactivation at
P1 (Supplementary Fig. 5d). Immunostaining further showed an
increased number of p21-expressing cardiomyocytes in E12.5 and
P3 Rest null hearts (Fig. 3a, b). We identiﬁed one conserved
REST-binding site (RE1 motif) located at the 3′ end of mouse p21
gene by sequence alignment between mouse and human (Fig. 3c).
Luciferase reporter gene assays and mutational analyses revealed
that the p21-RE1 motif was required for repressing transcription
in cultured P1 mouse cardiomyocytes (Fig. 3d). Quantitative
chromatin immunoprecipitation assays (qChIP) showed REST
occupancy of the p21-RE1 motif in E12.5 and P1 ventricles, but
the occupancy was greatly reduced in the ventricles of P21 when
REST level was largely diminished (Fig. 3e). Further, qChIP
showed that Rest deletion resulted in an enrichment of H3K4me3
histone modiﬁcation and a reduction of H3K9me3 and
H3K27me3 histone marks at the p21-RE1 motif (Fig. 3f). These
ﬁndings support that REST directly binds p21 and represses its
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Fig. 5 p21 deletion rescues neonatal heart defects resulting from Rest deletion. a Survival curve, no difference between control and p21 null (p21KO) or p21/
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sections showing that underdeveloped Rest null hearts are restored by p21 deletion (n= 5/group). Scale bar= 100 μm. d, e Echocardiograph showing p21
knockout rescues cardiac function resulting from Rest deletion at P1 (n= 6–8/group). f Representative western blot revealing upregulation of p21 and
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Immunostaining for cell cycle markers indicating p21 inactivation rescues the cell cycle defect resulting from Rest deletion (n= 4/group). Scale bar= 40
μm. Controls were the Tam-treated Rest+/+;TnTMerCreMer/+ mice. Mean± s.d. *p< 0.05 by one-way ANOVA followed by Tukey’s test
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02210-y
6 NATURE COMMUNICATIONS |8:  1979 |DOI: 10.1038/s41467-017-02210-y |www.nature.com/naturecommunications
transcription in cardiomyocytes, possibly through histone
methylation changes26.
To determine whether such repression promoted cardiomyo-
cyte proliferation during cardiac development, we deleted p21 in
RestmKO mice by breeding them with p21 knockout mice27.
Inactivation of p21 rescued embryonic lethality and cardiac
phenotypes of RestmKO mice at E12.5 (Fig. 4a–c). Inactivation of
p21 also restored the levels of Cyclin B, Cyclin E, and CDK1/2
(Fig. 4d), and re-established normal cardiomyocyte cell cycle
and proliferation, as indicated by recovered expression of
Ki67, PH3, and Aurora B, and EdU incorporation (Fig. 4e).
Double knockout (DKO) mice were survived to birth and
appeared healthy postnatally and in adulthood, with normal
cardiac morphology, heart/body weight ratio, and cardiac
function (Fig. 4f–i). Similarly, inactivation of p21 rescued
postnatal lethality of mice caused by inactivation of myocardial
Rest at P1 (Fig. 5a). Cardiac phenotypes were rescued, including
the cardiac size, heart/body ratio, cardiac function (Fig. 5b–e),
as well as the expression of cell cycle activators and markers
(Fig. 5f, g). We also examined whether forced overexpression of
REST would promote cardiomyocyte proliferation in cultured
cardiomyocytes isolated from P1 or P5 hearts. We ﬁrst treated the
culture with siRNAs against β-TrCP that mediates REST
degradation via ubiquitination21,25. The results of western blot
for REST, qRT-PCR for Rest, and REST-targeted genes and
immunostaining for EdU and PH3 showed that downregulation
of β-TrCP slowed down the REST degradation (Supplementary
Fig. 6a), suppressed the expression of REST target genes (Hcn2,
p21, Nppa, and Syn1) (Supplementary Fig. 6b), and upregulated
cardiomyocyte proliferation (Supplementary Fig. 6c). Next, we
overexpressed REST by transfection of a plasmid (pHR-NRSF-
CITE-GFP) containing Rest cDNA28 and found by western blot
and immunostaining for EdU and PH3 that overexpression of
REST dose-dependently repressed p21 expression and increased
cardiomyocyte proliferation (Supplementary Fig. 6d–f). These
ﬁndings, therefore, identify that a Rest-p21 axis underlies the
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regulation of cardiomyocyte cell cycle for fetal and neonatal
cardiac development.
Rest is required for regenerative cardiomyocyte proliferation.
To further investigate whether REST had a role in cardiac
regeneration, we investigated Rest expression in repairing neo-
natal hearts using an apical resection model4. Consistent with
previous reports4,6, immunostaining for the cell cycle markers
showed a signiﬁcantly increased number of cardiomyocytes that
re-entered the cell cycle in the injured region at P7, 3 days after
ablation at P4 (Fig. 6a). Notably, the number of REST-expressing
cardiomyocytes was also increased in the same region and was
correlated with the increased number of cells undergoing DNA
synthesis, mitosis, and division (Fig. 6b). The percentage of EdU+
cells that also expressed REST was sustained in the regenerating
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myocardium from P7 to P28 (Fig. 6c). About 90% of REST-
expressing cells in the apex undergoing repair were cardiomyo-
cytes; the reminder was epicardial or endocardial cells (Supple-
mentary Fig. 7a–d). These ﬁndings indicated that the majority of
REST-expressing cells were proliferating cardiomyocytes induced
by injury. We deleted Rest in the myocardium at P3 and per-
formed apical resection at P4. The P3 deletion bypassed the death
of neonates when Rest was deleted at P1, while apical ablation at
P4 was still within the window of myocardial regeneration2. We
found by Masson’s trichrome staining that the ﬁbrotic scar in the
apex of Rest null hearts (RestimKO) was not resolved at P14 and
P28 compared to the control hearts (Fig. 7a, b). Consistent with
the persistent scaring phenotype, RestimKO hearts had reduced left
ventricular function as observed by echocardiography (Fig. 7c, d).
Further, immunostaining revealed that the number of EdU+
proliferating cardiomyocytes in the injured apex of RestimKO
hearts was signiﬁcantly reduced (Fig. 7e–g). Together, these
ﬁndings suggest that REST re-expression is necessary for the
regeneration of neonatal hearts.
The increased number of REST-expressing cardiomyocytes in
the regenerating neonatal hearts was correlated with increased
REST occupancy at the p21-RE1 motif (Supplementary Fig. 8a).
Concurrently, the regenerating myocardium expressed a low level
of p21 mRNA (Supplementary Fig. 8b). Immunostaining also
showed that the number of p21-expressing cardiomyocytes was
negatively correlated with that of REST-expressing cells in the
regenerating myocardium (Supplementary Fig. 8c, d). In contrast,
p21 transcription was de-repressed in the injured RestimKO apex,
which was accompanied with downregulation of the cell cycle
activators (Supplementary Fig. 8e, f). To determine whether p21
upregulation was responsible for the reduced proliferation of
cardiomyocytes and poor regeneration of myocardium after Rest
deletion, we performed the apical resection on the Rest and p21
DKO hearts at P4, 1 day after Rest deletion (Fig. 8a). Like control
hearts, p21−/− hearts had normal left ventricular function at P28
(Fig. 8b, c). We noted that p21−/− hearts had less ﬁbrotic scar
tissue as compared to controls (Fig. 8d). Importantly, p21 deletion
improved regeneration and function of RestimKO hearts and
restored the number of EdU+ cardiomyocytes in the injured
myocardium (Fig. 4e). These results demonstrate that the Rest-
p21 axis regulation of cardiomyocyte proliferation also underlies
the neonatal cardiac regeneration.
Discussion
Overall, our study identiﬁes a molecular mechanism by which
REST repression of the cell cycle inhibitor p21 is necessary and
sufﬁcient for promoting the cardiomyocyte cell cycle and pro-
liferation during cardiac development and regeneration. p21 is a
well known cell cycle inhibitor through interacting with the G1/M
and G2/S CDK cyclins and inhibits their function to drive the cell
cycle29. Of particular note, p21 is the only cell cycle inhibitor gene
signiﬁcantly repressed by REST in the proliferating cardiomyo-
cytes during cardiac development and regeneration, suggesting
that REST repression of p21 is a major mechanism underlying the
regulation of cardiomyocyte cell cycle. Consistent with this
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notion, p21 deletion has been reported to enhance the regen-
eration of injured appendage30 and neonatal hearts31. Interest-
ingly, GATA432 and MEIS119 also repress p21 transcription in
mouse embryonic and injured neonatal hearts, respectively. Since
neither GATA4 nor MEIS1 expression is affected by REST
inactivation, REST repression of p21 is likely independent of
GATA4 and MEIS1. REST thus joins a network of transcription
factors or cofactors, including MEIS119, YAP15,16, GATA412,33,34,
and TBX2013, as a new member essential for cardiac development
and regeneration.
Elucidating the Rest-p21 axis underlying the regulation of
cardiomyocyte cell cycle may have clinical implications by pro-
viding an opportunity for better understanding of cardiomyocyte
proliferation in cardiac regeneration. It is well known that the cell
cycle arrest of cardiomyocytes is a normal physiological feature of
adult hearts5. This, however, prevents the endogenous regenera-
tion of infarcted adult hearts from the proliferation of pre-
existing cardiomyocytes11,35. Our studies indicate that REST is
rapidly diminished in the postnatal heart, but rebounded after
injury. These observations suggest that REST downregulation
might be one of the limiting factors for sustaining proliferation of
postnatal cardiomyocytes. Future investigations are needed to
determine whether REST is reactivated in adult hearts by injury
and if the reactivation promotes adult cardiac regeneration by
modulation of the activity of cardiomyocyte cell cycle.
Methods
Mouse strains. Floxed Restmice (RestGT/GT), which carries a conditional gene trap
(GT) cassette23, were bred to TnTCre36 or TnTMerCreMer37 mice to obtain Rest
deletion in myocardium. Intraperitoneal tamoxifen (TAM) injection at 40 mg/kg
was used for inducible inactivation. For rescue experiments, TnTCre; RestGT/GT
(RestmKO), or TnT MerCreMer;RestGT/GT (RestimKO) mice were crossed to p21−/−
(Cdkn1a−/−) mice27. All mouse stains were in the C57B6 background. Embryos
were isolated and inspected according to expected developmental ages. Age-
matched embryos and neonatal mice of both sexes were grouped according to
genotypes during experiments. Noontime on the day of detecting vaginal plugs was
designated as E0.5, and morning on the day of observing newborns was designated
as P0. The yolk sac or tail of mice was used for genotyping by PCR using Cre and
allele-speciﬁc primers (Supplementary Table 1). Mouse housing and experiments
were according to the protocols approved by the Institutional Animal Care and Use
Committee (IACUC) of Albert Einstein College of Medicine.
Neonatal heart apical resection. Neonatal mouse heart apical resection (AR) was
performed on postnatal day (P) 4 mice of both sexes as previously described4.
Brieﬂy, we induced deletion of Rest in the myocardium at P3 by tamoxifen and
performed apical resection at P4. P4 neonates were anesthetized by inhalation of
2% isoﬂurane and 100% oxygen on ice and then subjected to intercostal incisions to
separate the pericardium and expose the apex. The apex was amputated with
microsurgical scissors under a dissecting microscope. About 10% of the heart was
surgically removed to produce reproducible regeneration. The chest wall was then
closed with sutures and the skin incision was closed using skin adhesive. After the
operation, the neonates were placed back with the feeding female mice. Sham-
operated mice underwent the same procedure without apical resection.
Histology. Embryos or isolated hearts were ﬁxed in 4% paraformaldehyde (PFA),
dehydration, embedded in parafﬁn, and sectioned frontally at 6-μm thickness. H&E
and Masson’s trichrome staining were performed for detecting cardiac structure
defects and ﬁbrosis, respectively. The ﬁbrotic area was quantiﬁed using the
MetaMorph software (Molecular Devices).
Primary cardiomyocyte cultures. Cardiomyocytes (CMs) were isolated as
described in previous studies20. Ventricles were dissected out from P1 or P5
neonates of both sexes, minced and dissociated by 0.045% collagenase II and 0.08%
trypsin-EDTA at 37 °C. Non-CMs were removed through adhesive plating. Puriﬁed
CMs were cultured in 12-well plates for 24 h at 37 °C with 5% CO2 in Dulbecco’s
modiﬁed Eagle’s minimum essential medium (DMEM) supplemented with 10%
fetal calf serum.
siRNA and cDNA transfection. siRNA against β-TrCP (si-β-TrCP, Santa Cruz
Biotechnology) or plasmids containing mouse Rest cDNA (pHR-NRSF-CITE-GFP,
Addgene) was transfected into cultured neonatal cardiomyocytes isolated from P1
or P5 neonatal hearts, at 70% conﬂuency. Lipofectamine 3000 Regent (Invitrogen)
and si-β-TrCP (40 nM) or REST-cDNA (0.5 or 2 µg/ml) were incubated in
OPTIMEM (Invitrogen) for 15 min at RT, and then added to cells and incubated
for indicated time. qRT-PCR and western blot were used to conﬁrm the efﬁciency
and effect of transfection.
ChIP-qPCR. ChIP-qPCR assays were performed as previously reported38. Ven-
tricles (30–40 mg) from indicated stages were treated with 1% formaldehyde at
room temperature for 10 min to crosslink protein and DNA complexes before
quenched with addition of glycine. After three washes with PBS, tissues were
homogenized, lysed, and sonicated to shear DNAs into 100–500 bp fragments. The
DNA fragments were incubated with 5 µg antibodies against REST (EMD Milli-
pore, 17–641, 1:100), Tri-Methyl-Histone H3 (Lys9) (CST mAb #13969, 1:100),
Tri-Methyl-Histone H3 (Lys27) (CST mAb #9733, 1:100), Tri-Methyl-Histone H3
(Lys4) (CST mAb #9751, 1:100), or Acetyl-Histone H3 (Lys9) (CST mAb #9649,
1:100) overnight at 4 °C using Dynabead Protein G in a ﬁnal volume of 500 µl and
Magnet Starter Pack (Invitrogen, 10004D). Five microgram IgGs (Abcam,
ab171870) were used as control. Immunoprecipitated DNAs were extracted and
used for qPCR analysis to determine the enrichment of DNA fragments containing
the p21-RE1 using speciﬁc primers (Supplementary Table 1).
Western blot. Ventricles were collected at the indicated stages, homogenized in
radioimmunoprecipitation assay buffer at 4 °C and quantiﬁed by bicinchoninic
acid assay. Equal total proteins (20 μg) were resolved in SDS-PAGE gels and
transferred onto polyvinylidene ﬂuoride membranes (Immobilon, Millipore). The
membranes were blocked and incubated with primary antibodies at 4 °C overnight
before incubated with HRP-conjugated secondary antibodies. Protein bands were
detected by enhanced chemiluminescence. Antibodies, including REST (Anti-
bodies-online, ABIN747683, 1:1000), P21 (Abcam, ab109199, 1:500), Cyclin E
(Santa Cruz, sc-377100, 1:1000), Cyclin B (Santa Cruz, sc-166210, 1:1000), CDK1/
CDK2 (Santa Cruz, sc-53219, 1:1000), and GAPDH (Thermo Fisher, MA5-15738,
1:5000), were used in western blot analysis. Full scans of western blots are shown in
Supplementary Figs. 9–14.
Echocardiography. Echocardiography was performed using a Vevo 770 ultrasound
system (Visual Sonics, Toronto, Canada). Investigators were blinded to genotype
and treatment groups. Mice were anesthetized with 1.5% isoﬂurane and mouse
hearts were viewed on two-dimensional short-axis planes and measured using M-
mode. Heart rate, left ventricular internal diameter, interventricular septal, and
posterior wall (PW) dimensions were measured at end ystole and end diastole for
at least three cardiac cycles. Fractional shortening (FS) were calculated by the
average of FS measurements of the left ventricular contraction for ﬁve cardiac
cycles.
Quantitative reverse transcription PCR (qRT-PCR). Total RNAs were extracted
from ventricles or cultured CMs using TRIzol (Life Technologies). One microgram
of total RNAs was reverse transcribed to cDNA using a Superscript II reverse
transcriptase Kit (Life Technologies). qRT-PCR was performed using Power SYBR
Green PCR Master Mix (Life Technologies) and carried out on an Applied Bio-
systems 7900HT Fast Real-Time PCR System. Speciﬁc primers were listed in
Supplementary Table 1. The relative expression of each gene was normalized to the
expression of Gapdh and calculated using the 2−ΔΔCT method. Biological replicates
were performed using three individual samples of each genotype and technical
triplicates were carried out for each run of qPCR.
Luciferase reporter gene assay. Transcriptional suppression of p21 via the p21-
RE1-pGL3 enhancer by REST was evaluated using luciferase reporter gene assay as
described previously20. DNA fragment of p21 gene with or without mutation or
deletion of the p21-RE1 was PCR cloned into a PGL3 enhancer luciferase reporter
vector (Supplementary Table 1). All constructs were conﬁrmed by Sanger
sequencing. 0.8 µg of each p21-RE1-pGL3 enhancer construct was co-transfected
with 0.2 µg of pRL-SV40 vector (Promega, E2231) into cultured P1 CMs in 96-well
plates using Lipofectamine 3000 Reagents (Invitrogen). After 24 h transfection, cell
lysates were processed for luciferase activity using the luciferase reporter system
(Promega, E1980). Luciferase reporter activities were calculated as ﬁreﬂy luciferase
normalized to Renilla luciferase luminescence. Biological triplicates were per-
formed in technical triplicates for each vector.
Immunostaining. Immunostaining was performed on sections of parafﬁn-
embedded embryos or hearts, as previously described39. Embryos or hearts were
collected at the indicated stages and ﬁxed in 4% PFA for 2 h, rinsed in PBS,
dehydrated in 15 and 30% sucrose sequentially, embedded in optimal cutting
temperature (OCT) compound and sectioned at 8-μm thickness. Heart sections
were blocked with 5% horse serum for 1 h at room temperature before being
incubated overnight at 4 temperature with the single or double staining with fol-
lowing antibodies diluted in blocking solution: TnT (Fisher Scientiﬁc, MS-295-P0,
1:400), PECAM1 (Santa, sc-1506, 1:400), REST (Antibodies-online, ABIN747683,
1:400 dilution), Ki67 (Abcam, ab66155, 1:200), P21 (Abcam, ab109199, 1:100
dilution), cleaved caspase-3 (CST, mAb #9664, 1:200), phosphorylated-histone3
(pH3) (Abcam, ab32107, 1:200), or aurora B (Abcam, ab2254,1:100). After three
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washes with PBS for 5 min each, samples were stained for 1 h at room temperature
with ﬂuorescent secondary antibodies followed by DAPI (4′,6-diamidino-2-phe-
nylindole dihydrochloride) staining for nuclei visualization. Images were acquired
and analyzed using a Zeiss ﬂuorescence microscope with Axiovision image analysis
software. For parafﬁn sections, 6-µm tissue sections were de-waxed in xylene,
rehydrated in descending grades of alcohol and antigen-retried by incubating in
sodium citrate for 10 min at 95 °C. After blocked with 5% horse serum for 60 min,
sections were incubated with antibodies against NKX2.5 (Santa, sc-14033, 1:500)
overnight at 4 °C, followed by incubation with biotinylated secondary antibodies
(Vectastain, PK-6100) for 1 h and stained with DAB (Vector, SK-4100). Coun-
terstaining with hematoxylin was used for visualization of nuclei. All immunos-
taining were performed on four sections per sample, and total four samples of each
genotype and treatment group were experimented. Images were taken from six
ﬁelds per section, processed using ImageJ software and counted blindly to genotype
and treatment groups.
EdU incorporation. Proliferative cells were pulse labeled for 2 h by intraperitoneal
injection of mice with 5-ethynyl-2′-deoxyuridine (EdU, 100 mg/kg). Hearts were
then collected, ﬁxed in 4% PFA, rinsed in PBS, soaked in 15 and 30% sucrose
sequentially, embedded in OCT, and sectioned at 8-μm thickness. Sections were
stained with antibodies against TnT (Fisher Scientiﬁc, MS-295-P0, 1:400) or REST
(Antibodies-online, ABIN747683, 1:400), followed by EdU staining (Click-iT® EdU
Alexa Fluor® 488 Imaging Kit, Life Technologies) and DAPI counterstaining
(Vector lab, H1200). Stained sections were photographed under a Zeiss micro-
scope, and images were processed for quantitative analysis as described above.
Flow cytometry. P3 ventricles of Rest knockout (Restimko) mice and littermate
controls of both sexes were digested into single cell suspension, ﬁxed with 70%
ethanol. CMs were stained with TnT antibodies (Fisher Scientiﬁc, MS-295-P0,
1:400) for 2 h at room temperature and then incubated with secondary antibodies
(Alexa Fluor™ 488 Tyramide SuperBoost™ Kit, goat anti-mouse IgG). Cell pellets
were re-suspended in FxCycle™ PI/RNase Staining Solution (Fisher Scientiﬁc,
F10797) and analyzed on a FACStar Plus ﬂow cytometer (Becton Dickinson,
Franklin Lakes, NJ). An average of 104 CMs (FITC+) were collected in the gate
from total cells per ventricle using forward and side scatter. We used pulse width
versus pulse area as ﬁrst gate on the single cell population and then applied this
gate to the scatter plot to gate out cell debris. The combined gates were applied to
the PI histogram plot to obtain the percentage of cells in each cell cycle phase.
Apoptosis assay. Apoptotic cells were visualized by TUNEL assay. Frozen sections
were stained with TnT antibodies (Fisher Scientiﬁc, MS-295-P0, 1:400), followed by
TUNEL staining using a DeadEndTM Fluorometric TUNEL kit (Promega). After
DAPI counterstaining, sections were photographed under a Leica SP5 confocal
microscope. Stained sections were photographed, and images were processed for
quantitative analysis as described above.
Statistics. No statistical methods were used to predetermine sample size. Student’s
t test (two-tailed) or one-way ANOVA analysis followed by Tukey’s, Sidak’s, or
Bonferroni test was used for statistical difference between or among groups. The
relationship between REST expression and cell proliferation during cardiac
regeneration was analyzed by Pearson correlation coefﬁcient. Survival rate of mice
at various stages was calculated using log-rank (Mantel–Cox) test. Normality was
assumed and variance was compared between or among groups. Sample size was
determined based upon previous experience in the assessment of experimental
variability. The investigators were not blinded to the group allocation during
experiments and outcome assessment, unless stated otherwise. We chose the
adequate statistic tests according to the data distribution to fulﬁll test assumptions.
Statistical comparison for all quantitative assays was performed in at least three
independent experiments. All numerical data were presented as mean± s.d. and p
value of <0.05 was considered as signiﬁcant. Statistical analyses were performed
using the SPSS v16.0 software (SPSS Inc., Chicago, IL).
Data availability. Data supporting the ﬁndings of this study are available within
the article and its Supplementary Information ﬁles. All relevant data are available
from the authors on reasonable request. The RNA-Seq data have been downloaded
from the NIH GEO database with accession code GSE80378.
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